<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39361618</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Deciphering changes in the incidence of hemorrhagic stroke and cerebral venous sinus thrombosis during the coronavirus disease 2019 pandemic: A nationwide time-series correlation study.</ArticleTitle><Pagination><StartPage>e0301313</StartPage><MedlinePgn>e0301313</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0301313</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0301313</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Hemorrhagic stroke and cerebral venous sinus thrombosis (CVST) are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination. We aimed to investigate changes in the incidence of hemorrhagic stroke and CVST in South Korea before and during the coronavirus disease 2019 pandemic and the factors associated with these changes.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We conducted a nationwide time-series study using population-based databases between 2007 and 2022. The real-world and forecasted incidences of acute non-traumatic subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and CVST during the pandemic period (2020-2022) were estimated and compared with the pre-pandemic period (2007-2019). The prevalence of conventional risk factors was measured using time-series data. Finally, a time-series correlation analysis was performed to examine the temporal association between conventional risk factors, SARS-CoV-2 infection, and SARS-CoV-2 vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of hemorrhagic stroke (SAH and ICH) was lower during the pandemic than during the pre-pandemic period. This observed decrease was associated with a reduction in the prevalence of conventional risk factors but not with SARS-CoV-2 infection or vaccination. The incidence of CVST was higher during the pandemic than during the pre-pandemic period, which may be temporally related to SARS-CoV-2 vaccination (Pearson correlation coefficient [r] = 0.349, P = 0.031).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We report reassuring evidence of hemorrhagic stroke associated with SARS-CoV-2 infection and vaccination. However, awareness of CVST may be required for future vaccine rollouts and SARS-CoV-2 outbreaks.</AbstractText><CopyrightInformation>Copyright: © 2024 Hyeon Cho et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hyeon Cho</LastName><ForeName>Soo</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1904-3177</Identifier><AffiliationInfo><Affiliation>Department of Nursing, Graduate School of Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong Kyu</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Min Cheol</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Health Policy Division, Public Health Center, Yangpyeong County Office, Yangpyeong, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Euiho</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Integrative Medicine, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Yongin Severance Hospital, Yongin, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Seoncheol</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8158-2617</Identifier><AffiliationInfo><Affiliation>Department of Mathematics, Hanyang University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Natural Sciences, Hanyang University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Darda</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Korea University Anam Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Jongmok</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4886-7650</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Samsung Medical Center, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012851" MajorTopicYN="Y">Sinus Thrombosis, Intracranial</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083302" MajorTopicYN="Y">Hemorrhagic Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="N">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013345" MajorTopicYN="N">Subarachnoid Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361618</ArticleId><ArticleId IdType="pmc">PMC11449313</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0301313</ArticleId><ArticleId IdType="pii">PONE-D-24-10134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oonk NGM, Ettema AR, van Berghem H, de Klerk JJ, van der Vegt JPM, van der Meulen M. SARS-CoV-2 vaccine-related neurological complications. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2022;43(4):2295–2297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771172</ArticleId><ArticleId IdType="pubmed">35050428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisniega DC, Reynolds AS. Severe Neurologic Complications of SARS-CoV-2. Current treatment options in neurology. 2021;23(5):14. doi: 10.1007/s11940-021-00669-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11940-021-00669-1</ArticleId><ArticleId IdType="pmc">PMC8009931</ArticleId><ArticleId IdType="pubmed">33814894</ArticleId></ArticleIdList></Reference><Reference><Citation>Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology. 2021;20(10):795–820. doi: 10.1016/S1474-4422(21)00252-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00252-0</ArticleId><ArticleId IdType="pmc">PMC8443449</ArticleId><ArticleId IdType="pubmed">34487721</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara Y. Hemorrhagic stroke syndromes: clinical manifestations of intracerebral and subarachnoid hemorrhage. Handbook of clinical neurology. 2009;93:577–594. doi: 10.1016/S0072-9752(08)93028-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0072-9752(08)93028-1</ArticleId><ArticleId IdType="pubmed">18804669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropper AH, Klein JP. Cerebral Venous Thrombosis. The New England journal of medicine. 2021;385(1):59–64. doi: 10.1056/NEJMra2106545</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2106545</ArticleId><ArticleId IdType="pubmed">34192432</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Handunnetthi L, Saatci D, et al.. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144–2153. doi: 10.1038/s41591-021-01556-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01556-7</ArticleId><ArticleId IdType="pmc">PMC8629105</ArticleId><ArticleId IdType="pubmed">34697502</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi F, Bedston S, Lowthian E, et al.. Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales. Scientific reports. 2022;12(1):16406. doi: 10.1038/s41598-022-20118-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20118-6</ArticleId><ArticleId IdType="pmc">PMC9524320</ArticleId><ArticleId IdType="pubmed">36180455</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CR, Shi T, Vasileiou E, et al.. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine. 2021;27(7):1290–1297. doi: 10.1038/s41591-021-01408-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01408-4</ArticleId><ArticleId IdType="pmc">PMC8282499</ArticleId><ArticleId IdType="pubmed">34108714</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. The New England journal of medicine. 2021;384(22):2092–2101. doi: 10.1056/NEJMoa2104840</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, Sørvoll IH, Michelsen AE, et al.. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. 2021;384(22):2124–2130. doi: 10.1056/NEJMoa2104882</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully M, Singh D, Lown R, et al.. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. 2021;384(23):2202–2211. doi: 10.1056/NEJMoa2105385</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105385</ArticleId><ArticleId IdType="pmc">PMC8112532</ArticleId><ArticleId IdType="pubmed">33861525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Patone M, Mei XW, et al.. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ (Clinical research ed). 2021;374:n1931. doi: 10.1136/bmj.n1931</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1931</ArticleId><ArticleId IdType="pmc">PMC8388189</ArticleId><ArticleId IdType="pubmed">34446426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Heo N, Kwon D, Ha J. Deciphering changes in the incidence of the Guillain-Barré syndrome during the COVID-19 pandemic: a nationwide time-series correlation study. BMJ neurology open. 2022;4(2):e000378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9808757</ArticleId><ArticleId IdType="pubmed">36618976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HC, Lee H, Lee HH, et al.. Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women. Clinical hypertension. 2022;28(1):1. doi: 10.1186/s40885-021-00188-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40885-021-00188-w</ArticleId><ArticleId IdType="pmc">PMC8722090</ArticleId><ArticleId IdType="pubmed">34980274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahiya M, Eboreime E, Hyde A, et al.. International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases. Digestive diseases and sciences. 2022;67(6):2107–2122. doi: 10.1007/s10620-021-07076-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-021-07076-1</ArticleId><ArticleId IdType="pmc">PMC10291482</ArticleId><ArticleId IdType="pubmed">34091800</ArticleId></ArticleIdList></Reference><Reference><Citation>Saverino C, Swaine B, Jaglal S, et al.. Rehospitalization After Traumatic Brain Injury: A Population-Based Study. Archives of physical medicine and rehabilitation. 2016;97(2 Suppl):S19–25. doi: 10.1016/j.apmr.2015.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2015.04.016</ArticleId><ArticleId IdType="pubmed">25944501</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Thomas-Rüddel DO, Schettler A, et al.. Comparing the validity of different ICD coding abstraction strategies for sepsis case identification in German claims data. PloS one. 2018;13(7):e0198847. doi: 10.1371/journal.pone.0198847</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198847</ArticleId><ArticleId IdType="pmc">PMC6066203</ArticleId><ArticleId IdType="pubmed">30059504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Kwon D, Park S, Park SR, Chung D, Ha J. Temporal association between the age-specific incidence of Guillain-Barré syndrome and SARS-CoV-2 vaccination in Republic of Korea: a nationwide time-series correlation study. Osong public health and research perspectives. 2023;14(3):224–231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10522829</ArticleId><ArticleId IdType="pubmed">37415440</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslow NE, Day NE. Statistical methods in cancer research. Volume II—The design and analysis of cohort studies. IARC scientific publications. 1987(82):1–406.</Citation><ArticleIdList><ArticleId IdType="pubmed">3329634</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A, Caffo B. Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two Failures. The American Statistician. 2000;54(4):280–288.</Citation></Reference><Reference><Citation>Zeng Z, Chen J, Chen M, Ma F, Lv M, Zhang J. Risk factors for antiplatelet drug-associated intracranial hemorrhage: a systematic review and meta-analysis. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2022;43(12):6761–6769. doi: 10.1007/s10072-022-06326-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06326-y</ArticleId><ArticleId IdType="pubmed">35982361</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G, Leali N, Coccheri S, et al.. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet (London, England). 1996;348(9025):423–428. doi: 10.1016/s0140-6736(96)01109-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(96)01109-9</ArticleId><ArticleId IdType="pubmed">8709780</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke. 1996;27(11):2020–2025. doi: 10.1161/01.str.27.11.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.27.11.2020</ArticleId><ArticleId IdType="pubmed">8898809</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiozawa M, Koga M, Inoue H, et al.. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry. International journal of stroke: official journal of the International Stroke Society. 2023;18(8):986–995. doi: 10.1177/17474930231175807</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17474930231175807</ArticleId><ArticleId IdType="pmc">PMC10507992</ArticleId><ArticleId IdType="pubmed">37154598</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson P, Kelly PJ, Craig JC, Lindley RI, Webster AC. Risk of Stroke in Patients with ESRD. Clinical journal of the American Society of Nephrology: CJASN. 2015;10(9):1585–1592. doi: 10.2215/CJN.12001214</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12001214</ArticleId><ArticleId IdType="pmc">PMC4559522</ArticleId><ArticleId IdType="pubmed">26209158</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhunen V, Bakker MK, Ruigrok YM, Gill D, Larsson SC. Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study. Journal of the American Heart Association. 2021;10(22):e022277. doi: 10.1161/JAHA.121.022277</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.022277</ArticleId><ArticleId IdType="pmc">PMC8751955</ArticleId><ArticleId IdType="pubmed">34729997</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoozegar F, Ronksley PE, Sauve R, Menon BK. Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Frontiers in neurology. 2015;6:7. doi: 10.3389/fneur.2015.00007</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00007</ArticleId><ArticleId IdType="pmc">PMC4313700</ArticleId><ArticleId IdType="pubmed">25699010</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvis SM, Hiltunen S, Lindgren E, et al.. Cancer and risk of cerebral venous thrombosis: a case-control study. Journal of thrombosis and haemostasis: JTH. 2018;16(1):90–95. doi: 10.1111/jth.13903</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13903</ArticleId><ArticleId IdType="pubmed">29125690</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohoon KP, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study. The American journal of medicine. 2018;131(3):307–316.e302. doi: 10.1016/j.amjmed.2017.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2017.09.015</ArticleId><ArticleId IdType="pmc">PMC5817009</ArticleId><ArticleId IdType="pubmed">28987552</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrieze SI. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychological methods. 2012;17(2):228–243. doi: 10.1037/a0027127</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0027127</ArticleId><ArticleId IdType="pmc">PMC3366160</ArticleId><ArticleId IdType="pubmed">22309957</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker RI, Hagan-Burke S. Useful effect size interpretations for single case research. Behavior therapy. 2007;38(1):95–105. doi: 10.1016/j.beth.2006.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2006.05.002</ArticleId><ArticleId IdType="pubmed">17292698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje AR, Abdulle AE, Timens W, et al.. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of pathology. 2020;251(3):228–248. doi: 10.1002/path.5471</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Tong X, George MG, Chang A, Merritt RK. COVID-19 and Risk of Acute Ischemic Stroke Among Medicare Beneficiaries Aged 65 Years or Older: Self-Controlled Case Series Study. Neurology. 2022;98(8):e778–e789. doi: 10.1212/WNL.0000000000013184</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013184</ArticleId><ArticleId IdType="pmc">PMC8935393</ArticleId><ArticleId IdType="pubmed">35115387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu TM, Seet CYH, Koh JS, et al.. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men. JAMA network open. 2021;4(4):e217498. doi: 10.1001/jamanetworkopen.2021.7498</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.7498</ArticleId><ArticleId IdType="pmc">PMC8063067</ArticleId><ArticleId IdType="pubmed">33885771</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al.. Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients. Neurocritical care. 2022;36(1):259–265. doi: 10.1007/s12028-021-01297-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-021-01297-y</ArticleId><ArticleId IdType="pmc">PMC8260011</ArticleId><ArticleId IdType="pubmed">34231186</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al.. Subarachnoid Hemorrhage and COVID-19: An Analysis of 282,718 Patients. World neurosurgery. 2021;151:e615–e620. doi: 10.1016/j.wneu.2021.04.089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.04.089</ArticleId><ArticleId IdType="pmc">PMC8086384</ArticleId><ArticleId IdType="pubmed">33940263</ArticleId></ArticleIdList></Reference><Reference><Citation>Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. J Neurol Neurosurg Psychiatry. 2022. doi: 10.1136/jnnp-2022-329200</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329200</ArticleId><ArticleId IdType="pubmed">35902229</ArticleId></ArticleIdList></Reference><Reference><Citation>Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. Intracerebral hemorrhage in COVID-19: A narrative review. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2021;89:271–278. doi: 10.1016/j.jocn.2021.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.05.019</ArticleId><ArticleId IdType="pmc">PMC8096173</ArticleId><ArticleId IdType="pubmed">34119280</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiles LEP, Diamante PAB, Pascual JLV. Impact of the COVID-19 Pandemic in the Acute Stroke Admissions and Outcomes in a Philippine Tertiary Hospital. Cerebrovascular diseases extra. 2022;12(2):76–84. doi: 10.1159/000525057</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525057</ArticleId><ArticleId IdType="pmc">PMC9247441</ArticleId><ArticleId IdType="pubmed">35588704</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson K, Tofiq A, Mathew A, Cao Y, von Euler M, Ström JO. Changes in stroke and TIA admissions during the COVID-19 pandemic: A meta-analysis. European stroke journal. 2023:23969873231204127. doi: 10.1177/23969873231204127</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23969873231204127</ArticleId><ArticleId IdType="pmc">PMC10916820</ArticleId><ArticleId IdType="pubmed">37776062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Lee H, Park J, et al.. Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study. Scientific reports. 2023;13(1):21724. doi: 10.1038/s41598-023-49055-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49055-8</ArticleId><ArticleId IdType="pmc">PMC10709599</ArticleId><ArticleId IdType="pubmed">38066091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PJ, Mosley SA, Ng TMH, Shooshtari A, Alexander GC, Qato DM. Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018–2021). American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists. 2023;80(11):692–698. doi: 10.1093/ajhp/zxac381</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/zxac381</ArticleId><ArticleId IdType="pubmed">36571281</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanon A, Grasic K, Chen S, et al.. The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis. BMC public health. 2023;23(1):2443. doi: 10.1186/s12889-023-17282-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-17282-3</ArticleId><ArticleId IdType="pmc">PMC10702024</ArticleId><ArticleId IdType="pubmed">38062484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2020;29(8):104949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221373</ArticleId><ArticleId IdType="pubmed">32410807</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi MIA, Azam B, Waheed MA, Imran A. Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine. BMJ case reports. 2022;15(5). doi: 10.1136/bcr-2021-247493</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-247493</ArticleId><ArticleId IdType="pmc">PMC9125703</ArticleId><ArticleId IdType="pubmed">35606039</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhashim A, Hadhiah K, Al Khalifah Z, et al.. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman. The American journal of case reports. 2022;23:e934744. doi: 10.12659/AJCR.934744</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.934744</ArticleId><ArticleId IdType="pmc">PMC8842441</ArticleId><ArticleId IdType="pubmed">35136010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>